These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27092832)

  • 1. Interpretation of Clinical Trials That Stopped Early.
    Viele K; McGlothlin A; Broglio K
    JAMA; 2016 Apr; 315(15):1646-7. PubMed ID: 27092832
    [No Abstract]   [Full Text] [Related]  

  • 2. Early stopping rules in oncology: considerations for clinicians.
    Mukherjee SD; Goffin JR; Taylor V; Anderson KK; Pond GR
    Eur J Cancer; 2011 Nov; 47(16):2381-6. PubMed ID: 21684153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility.
    Walter SD; Han H; Briel M; Guyatt GH
    Stat Med; 2017 Apr; 36(9):1506-1518. PubMed ID: 28183155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised controlled trials in oncology closed early for benefit: trends in methodology, results, and interpretation.
    Booth CM; Ohorodnyk P; Zhu L; Tu D; Meyer RM
    Eur J Cancer; 2011 Apr; 47(6):854-63. PubMed ID: 21296570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of conditional bias-adjusted estimators for interim analysis in clinical trials with survival data.
    Shimura M; Gosho M; Hirakawa A
    Stat Med; 2017 Jun; 36(13):2067-2080. PubMed ID: 28211076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data monitoring committees, interim analysis and early termination in paediatric trials.
    Fernandes RM; van der Lee JH; Offringa M
    Acta Paediatr; 2011 Oct; 100(10):1386-92. PubMed ID: 21434998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to interpret a randomized controlled study stopped early.
    Leandro G
    Intensive Care Med; 2013 Sep; 39(9):1642-3. PubMed ID: 23797787
    [No Abstract]   [Full Text] [Related]  

  • 8. Early Termination of Randomized Clinical Trials in Orthopaedics.
    Piuzzi N; Chughtai M; Khlopas A; Gwam CU; Muschler G; Spindler KP; Mont MA
    Surg Technol Int; 2017 Feb; 30():290-294. PubMed ID: 28182822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pocock approach to sequential meta-analysis of clinical trials.
    Shuster JJ; Neu J
    Res Synth Methods; 2013 Sep; 4(3):269-79. PubMed ID: 24348752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dangers of stopping a trial too early.
    Briel M; Bassler D; Wang AT; Guyatt GH; Montori VM
    J Bone Joint Surg Am; 2012 Jul; 94 Suppl 1():56-60. PubMed ID: 22810449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stopping guidelines for an effectiveness trial: what should the protocol specify?
    Tyson JE; Pedroza C; Wallace D; D'Angio C; Bell EF; Das A
    Trials; 2016 May; 17(1):240. PubMed ID: 27165260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [GRADE guidelines: 5. Rating the quality of evidence: publication bias].
    Nolting A; Perleth M; Langer G; Meerpohl JJ; Gartlehner G; Kaminski-Hartenthaler A; Schünemann HJ
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(9):670-6. PubMed ID: 23200211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stopping clinical trials early for futility: retrospective analysis of several randomised clinical studies.
    Jitlal M; Khan I; Lee SM; Hackshaw A
    Br J Cancer; 2012 Sep; 107(6):910-7. PubMed ID: 22878376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of protocols and publications suggested that most discontinuations of clinical trials were not based on preplanned interim analyses or stopping rules.
    Stegert M; Kasenda B; von Elm E; You JJ; Blümle A; Tomonaga Y; Saccilotto R; Amstutz A; Bengough T; Briel M;
    J Clin Epidemiol; 2016 Jan; 69():152-60. PubMed ID: 26361993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stopping clinical trials because of treatment ineffectiveness: a comparison of a futility design with a method of stochastic curtailment.
    Whitehead J; Matsushita T
    Stat Med; 2003 Mar; 22(5):677-87. PubMed ID: 12587099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous safety monitoring for randomized controlled clinical trials with blinded treatment information. Part 2: Statistical considerations.
    Ball G; Piller LB
    Contemp Clin Trials; 2011 Sep; 32 Suppl 1():S5-7. PubMed ID: 21664986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive Bayesian randomized trials: realizing their potential.
    Pullenayegum EM
    J Bone Joint Surg Am; 2012 Jul; 94 Suppl 1():29-33. PubMed ID: 22810444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interim analysis in randomized trials: DAMOCLES' sword?
    Besselink MG; van der Graaf Y; Gooszen HG
    J Clin Epidemiol; 2010 Apr; 63(4):353-4. PubMed ID: 19959333
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized two-stage Phase II clinical trial designs based on Barnard's exact test.
    Shan G; Ma C; Hutson AD; Wilding GE
    J Biopharm Stat; 2013; 23(5):1081-90. PubMed ID: 23957517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Publication bias in the anesthesiology literature.
    De Oliveira GS; Chang R; Kendall MC; Fitzgerald PC; McCarthy RJ
    Anesth Analg; 2012 May; 114(5):1042-8. PubMed ID: 22344237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.